In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orion: Overcoming Inexperience

Executive Summary

Finland's mid-80s decision to expand patenting inspired Orion Pharma to begin its own research. The firm quickly showed itself to be innovative and productive: coming up with several drugs interesting to Big Pharma licensees. But Orion has had difficulty turning its scientific achievement into commercial success. Partnering has not always gone well, while lack of management structures and limited funding have also hindered progress. Recent setbacks with Simdax, a drug for heart failure, spotlight the challenges of running effective clinical trials and gathering data for international regulators. Orion says it has learned its lessons, and instituted changes to help it overcome past problems. R&D and commercial operations are more closely managed; priorities are set and respected. The firm believes it can still make a success of Simdax, and has even higher hopes for the anti-anxiety drug that's next in its pipeline. A new partnership with Pharmacia brings it cash and expert assistance. Orion seems increasingly aware of, and able to meet, the challenges of being a Scandinavian company in a competitive international industry.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel